FN1 and cholangiocarcinoma: In our previous study, we evaluated the expressions of the αvβ6, α6β4, and α3β1 integrins and their ligands, fibronectin and laminin, in cholangiolocellular carcinoma (CLC), cholangiocarcinoma, and HCC.